The Thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis
β Scribed by Fu-Sheng Chou; James C. Mulloy
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 288 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
β¦ Synopsis
Hematopoietic stem cells (HSC) comprise a small percentage of total hematopoietic cells. Their ability to self-renewal is key to the continuous replenishment of the hematopoietic system with newly formed functional blood cell types while maintaining their multipotential capacity. Understanding the extrinsic signals that are essential to HSC maintenance will provide insights into the regulation of hematopoiesis at its most primitive stage, and with the knowledge applied, will potentially lead to improved clinical transplantation outcomes. In this review, we will summarize the current understanding of the role of the thrombopoietin/MPL signaling pathway in HSC maintenance during adult and fetal hematopoiesis. We will also speculate on the downstream key players in the pathway based on published data, and summarize the role of this pathway in leukemia.
π SIMILAR VOLUMES
## Abstract Human NUDC (hNUDC) was initially characterized as a nuclear migration protein based on the similarity of its Cβterminus to that of fungal NUDC from __Aspergillus nidulans__. However, hNUDC is a 331 amino acid protein whereas fungal NUDC is 198 amino acids in length. The extra Nβterminal
## Objective: To examine the prevalence, clinical associations, and pathogenic role of autoantibodies to c-mpl, the thrombopoietin (tpo) receptor, in patients with systemic lupus erythematosus (sle). ## Methods: Sera from 69 sle patients, 84 patients with idiopathic thrombocytopenic purpura (itp)